Evidence map›Paper›PMID 22001530›Full record

ArticleBiochimica et biophysica acta2012

PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Igor Gurevich, Carmen Zhang, Priscilla C Encarnacao, Charles P Struzynski, Sarah E Livings, Brian J Aneskievich

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Repressive Control of Keratinocyte Cytoplasmic Inflammatory Signaling.International journal of molecular sciences · 2023
    Review
  5. A20-Binding Inhibitor of NF-Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  6. Article
  7. Article
  8. TNIP1 RegulatesFrontiers in immunology · 2018
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Igor GurevichGraduate Program in Pharmacology & Toxicology, University of Connecticut, Storrs, CT 06269-3092, USA. igor.gurevich@huskymail.uconn.edu
Carmen Zhang
Priscilla C Encarnacao
Charles P Struzynski
Sarah E Livings
Brian J Aneskievich
University of Connecticut · US

Funding

Keratinocyte Nuclear Receptor CoactivatorsR01AR048660 · NIAMS · UNIVERSITY OF CONNECTICUT STORRS · PI ANESKIEVICH, BRIAN J · 2005 to 2009
$1.4M
NIAMS NIH HHS AR048660NIAMS NIH HHS R01 AR048660
6 · The paper itself

Abstract

Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFα-induced signaling through its interaction with NF-κB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR). The wide tissue distribution of TNIP1 provides the opportunity to influence numerous cellular responses in these roles and defining control of TNIP1 expression would be central to improved understanding of its impact on cell function. We cloned 6kb of the human TNIP1 promoter and performed predictive and functional analyses to identify regulatory elements. The promoter region proximal to the transcription start site is GC-rich without a recognizable TATA box. In contrast to this proximal ~500bp region, 6kb of the promoter increased reporter construct constitutive activity over five-fold. Throughout the 6kb length, in silico analysis identified several potential binding sites for both constitutive and inducible transcription factors; among the latter were candidate NF-κB binding sequences and peroxisome proliferator response elements (PPREs). We tested NF-κB and PPAR regulation of the endogenous TNIP1 gene and cloned promoter by expression studies, electrophoretic mobility shift assays, and chromatin immunoprecipitations. We validated NF-κB sites in the TNIP1 promoter proximal and distal regions as well as one PPRE in the distal region. The ultimate control of the TNIP1 promoter is likely to be a combination of constitutive transcription factors and those subject to activation such as NF-κB and PPAR.

Indexed as

Promoter Regions, GeneticBase SequenceBinding SitesDNA-Binding ProteinsGene Expression RegulationHeLa CellsHumansMolecular Sequence DataNF-kappa BPeroxisome Proliferator-Activated ReceptorsPPAR gammaProtein BindingRegulatory Sequences, Nucleic AcidResponse ElementsSignal TransductionTranscriptional ActivationDNA-Binding ProteinsNF-kappa BPeroxisome Proliferator-Activated ReceptorsPPAR gammaTNIP1 protein, humanTranscription Factor RelA

Identifiers

PMID22001530
PMCPMC3249470
OpenAlexW2030863339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.